F
N. Morita et al.
Special Topic
Synthesis
IR (KBr): 2955, 2836, 1603, 1508, 1464, 1437, 1396, 1337, 1319, 1232,
1205, 1178, 1119, 1082, 1036, 980, 885, 866, 841, 814, 781, 737 cm–1
(10) For dimerization with catalysts, see: (a) Kouznetsov, V. V.;
Merchan Arenas, D. R. Tetrahedron Lett. 2009, 50, 1546.
(b) Gonzalez-de-Castro, A.; Xiao, J. J. Am. Chem. Soc. 2015, 137,
8206.
(11) For dimerization with Brønsted acid, see: (a) Davis, M. C.;
Guenthner, A. J.; Groshens, T. J.; Reams, J. T.; Mabry, J. M.
J. Polym. Sci., Part A: Polym. Chem. 2012, 50, 4127. (b) Alvarez-
Thon, L.; Carrasco-Altamirano, H.; Espinoza-Catálan, L.;
Gallardo-Araya, C.; Cardona-Villada, W.; Ibañez, A. Acta Crystal-
logr. 2006, E62, o2000. (c) Al-Farhan, E.; Keehn, P. M.; Stevenson,
R. J. Chem. Res., Synop. 1992, 100. (d) Al-Farhan, E.; Keehn, P. M.;
Stevenson, R. J. Chem. Res., Synop. 1992, 36.
.
1H NMR (300 MHz, CDCl3 ): δ = 0.98 (t, J = 7.5 Hz, 3 H), 1.17 (d, J = 6.9
Hz, 3 H), 1.54–1.42 (m, 1 H), 1.84 (ddd, J = 10.5, 7.5, 2.7 Hz, 1 H), 2.07
(ddq, J = 9.6, 7.2, 2.7 Hz, 1 H), 2.68 (dt, J = 9.0, 3.6 Hz, 1 H), 3.38 (s, 3
H), 3.64 (s, 3 H), 3.83 (s, 3 H), 3.85 (s, 3 H), 3.85 (s, 3 H), 3.88 (s, 3 H),
4.29 (d, J = 3.9 Hz, 1 H), 6.38 (s, 1 H), 6.43 (s, 1 H), 6.55 (s, 1 H).
13C NMR (75 MHz, CDCl3): δ = 11.8, 22.0, 26.7, 47.7, 49.9, 52.4, 55.5,
56.1, 56.6, 56.7, 56.8, 59.9, 97.0, 97.9, 113.0, 127.0, 127.6, 139.2,
139.7, 142.7, 147.5, 151.2, 152.0, 152.2.
HRMS (FAB): m/z [M + H]+ calcd for C24H32O6: 416.2199; found:
416.2189.
(12) For dimerization with silica-supported acids or solid acids, see:
(a) Alesso, E.; Torviso, R.; Erlich, M.; Finkielsztein, L.; Lantaño,
B.; Moltrasio, G.; Aguirre, J.; Vázquez, P.; Pizzio, L.; Cáceres, C.;
Blanco, M.; Thomas, H. Synth. Commun. 2002, 32, 3803.
(b) Alesso, E. N.; Aguirre, J.; Lantaño, B.; Finkielsztein, L.;
Moltrasio, G. Y.; Vázquez, P. G.; Pizzio, L. R.; Caceres, C.; White,
M.; Thomas, H. J. Molecules 2000, 5, 414. For other examples,
see: (c) Grigor’eva, N. G.; Talipova, R. R.; Korzhova, L. F.;
Vosmerikov, A. V.; Kutepov, B. I.; Dzheimilev, U. M. Russ. Chem.
Bull. 2009, 58, 59. (d) Madhavan, D.; Murugalakshmi, M.;
Lalitha, A.; Pitchumani, K. Catal. Lett. 2001, 73, 1. (e) Benito, A.;
Corma, A.; García, H.; Primo, J. Appl. Catal., A 1994, 116, 127.
(13) For intramolecular coupling reaction of 1-phenylpropan-1-ols
with 1-phenylpropenes, see: Sarnpitak, P.; Trongchit, K.;
Kostenko, Y.; Sathalalai, S.; Gleeson, M. P.; Ruchirawat, S.;
Ploypradith, P. J. Org. Chem. 2013, 78, 8281.
Acknowledgment
This research was supported by grants from the Platform Project for
Supporting Drug Discovery and Life Science Research (Platform for
Drug Discovery, Informatics, and Structural Life Science) of the Minis-
try of Education, Culture, Sports, Science (MEXT), and the Japan
Agency for Medical Research and Development (AMED).
Supporting Information
Supporting information for this article is available online at
S
u
p
p
ortiInfogrmoaitn
S
u
p
p
ortioInfgrmoaitn
(14) For intermolecular coupling reaction of 1-phenylpropan-1-ols
with 1-phenylpropenes, see: (a) Li, H.-H. Chin. Chem. Lett. 2015,
26, 320. (b) Lantaño, B.; Aguirre, J. M.; Ugliarolo, E. A.; Benegas,
M. L.; Moltrasio, G. Y. Tetrahedron 2008, 64, 4090. (c) Pizzio, L.
R.; Vázquez, P. G.; Cáceres, C. V.; Blanco, M. N.; Alesso, E. N.;
Torviso, M. R.; Lantaño, B.; Moltrasio, G. Y.; Aguirre, J. M. Appl.
References
(1) For reviews on lignans and neolignans, see: (a) Saleem, M.; Kim,
H. J.; Ali, M. S.; Lee, Y. S. Nat. Prod. Rep. 2005, 22, 696.
(b) MacRae, W. D.; Towers, G. H. N. Phytochemistry 1984, 23,
1207. (c) Ward, R. S. Chem. Soc. Rev. 1982, 11, 75.
(2) In earliest researches, 2,3-dihydro-1H-indene derivatives were
originally thought to be derivatives of cyclobutane or 9,10-dihy-
droanthracene. The skeletons of 2,3-dihydro-1H-indenes were
first proposed by Baker et al. in 1940, and MacMillan et al.
assigned the correct stereochemical structure for the dimers
derived from (E)-isosafrole and isohomogenol in 1969:
(a) Baker, W.; Enderby, J. J. Chem. Soc. 1940, 1094.
(b) MacMillan, J.; Martin, I. L.; Morris, D. J. Tetrahedron 1969, 25,
905.
Catal.,
A 2005, 287, 1. (d) Lantaño, B.; Aguirre, J. M.;
Finkielsztein, L.; Alesso, E. N.; Brunet, E.; Moltrasio, G. Y. Synth.
Commun. 2004, 34, 625. (e) Alesso, E.; Torviso, R.; Lantaño, B.;
Erlich, M.; Finkielsztein, L. M.; Moltrasio, G.; Aguirre, J. M.;
Brunet, E. ARKIVOC 2003, : 283. (f) Angle, S. R.; Arnaiz, D. O.
J. Org. Chem. 1992, 57, 5937.
(15) For gold-catalyzed reactions in ionic liquids, see: (a) Lempke, L.;
Fischer, T.; Bell, J.; Kraus, W.; Rurack, K.; Krause, N. Org. Biomol.
Chem. 2015, 13, 3787. (b) Cui, D.-M.; Ke, Y.-N.; Zhuang, D.-W.;
Wang, Q.; Zhang, C. Tetrahedron Lett. 2010, 51, 980. (c) Neaţu, F.;
Pârvulescu, V. I.; Michelet, V.; Gênet, J.-P.; Goguet, A.; Hardacre,
C. New J. Chem. 2009, 33, 102. (d) Aksin, Ö.; Krause, N. Adv.
Synth. Catal. 2008, 350, 1106. (e) Ambrogio, I.; Arcadi, A.;
Cacchi, S.; Fabrizi, G.; Marinelli, F. Synlett 2007, 1775. (f) Liu, X.;
Pan, Z.; Shu, X.; Duan, X.; Liang, Y. Synlett 2006, 1962.
(16) (a) Lee, J. W.; Shin, J. Y.; Chun, Y. S.; Jang, H. B.; Song, C. E.; Lee,
S.-g. Acc. Chem. Res. 2010, 43, 985. (b) Park, B. Y.; Ryu, K. Y.;
Park, J. H.; Lee, S.-g. Green Chem. 2009, 11, 946. (c) Kim, J. H.;
Lee, J. W.; Shin, U. S.; Lee, J. Y.; Lee, S.-g.; Song, C. E. Chem.
Commun. 2007, 4683. (d) Song, C. E.; Jung, D.-u.; Choung, S. Y.;
Roh, E. J.; Lee, S.-g. Angew. Chem. Int. Ed. 2004, 43, 6183.
(e) Song, C. E.; Shim, W. H.; Roh, E. J.; Lee, S.-g.; Choi, J. H. Chem.
Commun. 2001, 1122. (f) Song, C. E.; Shim, W. H.; Roh, E. J.; Choi,
J. H. Chem. Commun. 2000, 1695.
(3) Puxeddu, E. Gazz. Chim. Ital. 1909, 39, 131.
(4) (a) Saxena, D. B. Phytochemistry 1986, 25, 553. (b) Bohlmann, F.;
Gracza, L. Arch. Pharm. (Weinheim) 1982, 315, 474.
(5) (a) Atsumi, T.; Tonosaki, K.; Fujisawa, S. Arch. Oral Biol. 2006, 51,
913. (b) Atsumi, T.; Murakami, Y.; Shibuya, K.; Tonosaki, K.;
Fujisawa, S. Anticancer Res. 2005, 25, 4029.
(6) Murakami, Y.; Shoji, M.; Hirata, A.; Tanaka, S.; Yokoe, I.;
Fujisawa, S. Arch. Biochem. Biophys. 2005, 434, 326.
(7) Ko, F.-N.; Liao, C.-H.; Kuo, Y.-H.; Lin, Y.-L. Biochim. Biophys. Acta
1995, 1258, 145.
(8) Lin, C.-H.; Kuo, Y.-H.; Lin, Y.-L.; Teng, C.-M. J. Pharm. Pharmacol.
1994, 46, 54.
(9) Danilova, L. I.; Ivanova, I. Ya.; Kozlova, Z. G.; Kore, S. A.; Livshits,
A. G.; Osipova, V. P.; Tsepalov, V. F.; Shlyapintokh, V. Ya. Patent
SU No. 224741, 1968.
(17) (a) Clement, N. D.; Cavell, K. J. Angew. Chem. Int. Ed. 2004, 43,
3845. (b) McGuinness, D. S.; Cavell, K. J.; Yates, B. F. Chem.
Commun. 2001, 355. (c) Mathews, C. J.; Smith, P. J.; Welton, T.;
White, A. J. P.; Williams, D. J. Organometallics 2001, 20, 3848.
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2016, 48, A–G